Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
Merck Sharp & Dohme LLC
University College, London
Canadian Cancer Trials Group
City of Hope Medical Center
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Children's Oncology Group
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
City of Hope Medical Center
The Affiliated People's Hospital of Ningbo University
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine
Seagen Inc.
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
University of Miami
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
University of Liverpool
First Affiliated Hospital of Zhejiang University
Children's Oncology Group
St. Jude Children's Research Hospital
Case Comprehensive Cancer Center
Children's Oncology Group
Washington University School of Medicine
University of Nebraska
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center